As a result of DUR program requirements in the Medicaid Final Rule (CMS-2390-F), which applies to Medicaid managed care organizations (MCOs) & CHIP programs, pharmacists must consult beneficiary records to identify drug-disease contraindications or ask about drug-allergy issues at the point-of-sale and provide patient counseling as needed.